Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01094327 · ClinicalTrials.gov registry record
Proteinuria in Pre and Post Transplant
A clinical trial of Proteinuria, sponsored by University of Miami.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT01094327: Recruiting study of Proteinuria, sponsored by University of Miami.
NCT01094327 is a study of Proteinuria that is actively recruiting participants, run by University of Miami. The registered enrollment target is 100 participants, below the 196-participant average among 10 other Proteinuria trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01094327, a study of Proteinuria, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with focal segmental glomerulosclerosis (FSGS) who progress rapidly to end stage renal disease (ESRD) are at highest risk for development of recurrence of proteinuria following kidney transplantation. This study will look at serum specimens pre and post transplant, as well as kidney transplant specimens pre and post reperfusion to identify where the defects has occured that results in recurrence of proteinuria in a given kidney transplant.
Primary Outcome
chart review
Conditions Studied
Study Locations (1)
Florida
- University of Miami Miller School of Medicine Transplant Clinic - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-02 |
| Est. Completion | 2026-11-30 |
What NCT01094327 shows while recruiting
NCT01094327 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 196-participant average among 10 other Proteinuria trials with a reported enrollment target (49% lower).
The record links to 1 condition, with Proteinuria appearing as the primary indexed condition, and to 0 interventions.
NCT01094327 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01094327 about?
NCT01094327 is a clinical study titled "Proteinuria in Pre and Post Transplant". Patients with focal segmental glomerulosclerosis (FSGS) who progress rapidly to end stage renal disease (ESRD) are at highest risk for development of recurrence of proteinuria following kidney transplantation. This study will look at serum specimens pre and post transplant, as well as kidney transpl...
What is the current status of trial NCT01094327?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2008-02. Estimated completion is 2026-11-30.
What conditions does trial NCT01094327 study?
This clinical trial studies the following conditions: Proteinuria.
Who is sponsoring clinical trial NCT01094327?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01094327 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Proteinuria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01094327's enrollment target sits among peer trials
100 3rd of 10 higher than 7 of 10 other Proteinuria trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Proteinuria trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
RECRUITING · Phase 3
-
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
RECRUITING · Phase 2
-
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
RECRUITING · Phase 4
-
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
RECRUITING · Phase 3
-
Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
COMPLETED · Phase 3
-
Belatacept Conversion in Proteinuric Kidney Transplant Recipients
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia